Shaolin Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
LA
LP
MF
AA
PAMP
RCM
TCM
AIMCA
Shaolin Capital Management's TDACW Position: Q2 2026 in Review
Shaolin Capital Management reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 43% in Q2 2026, selling an estimated $275K and leaving 367,253 shares worth $523K. The position accounts for 0.03% of the portfolio, ranked #283.
Shaolin Capital Management first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.
- Shaolin Capital Management held 367,253 shares of Translational Development Acquisition Corp Warrants worth $523K as of Q2 2026.
- Shaolin Capital Management sold 274,466 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $275K.
- Translational Development Acquisition Corp Warrants made up 0.03% of Shaolin Capital Management's portfolio in Q2 2026, its #283 holding.
- Shaolin Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
- 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.
Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.